HUT72922A - Expression system using autolysable fusion protein and new reducing polypeptides - Google Patents

Expression system using autolysable fusion protein and new reducing polypeptides Download PDF

Info

Publication number
HUT72922A
HUT72922A HU9502114A HU9502114A HUT72922A HU T72922 A HUT72922 A HU T72922A HU 9502114 A HU9502114 A HU 9502114A HU 9502114 A HU9502114 A HU 9502114A HU T72922 A HUT72922 A HU T72922A
Authority
HU
Hungary
Prior art keywords
sequence
polypeptide
protein
amino acid
dna
Prior art date
Application number
HU9502114A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9502114D0 (en
Inventor
Ichiro Kawashima
Ryuta Koishi
Nobufusa Serizawa
Tohru Takahashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP30380994A external-priority patent/JP3337178B2/ja
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HU9502114D0 publication Critical patent/HU9502114D0/hu
Publication of HUT72922A publication Critical patent/HUT72922A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0051—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5431—IL-11
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
HU9502114A 1994-07-13 1995-07-12 Expression system using autolysable fusion protein and new reducing polypeptides HUT72922A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16105394 1994-07-13
JP21839294 1994-09-13
JP30380994A JP3337178B2 (ja) 1994-07-13 1994-12-07 クローバーイエローベインウイルスプロテアーゼ

Publications (2)

Publication Number Publication Date
HU9502114D0 HU9502114D0 (en) 1995-09-28
HUT72922A true HUT72922A (en) 1996-06-28

Family

ID=27321781

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9502114A HUT72922A (en) 1994-07-13 1995-07-12 Expression system using autolysable fusion protein and new reducing polypeptides
HU0202280A HU0202280D0 (enExample) 1994-07-13 1995-07-12

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU0202280A HU0202280D0 (enExample) 1994-07-13 1995-07-12

Country Status (14)

Country Link
US (3) US5955072A (enExample)
EP (2) EP1251176A3 (enExample)
KR (1) KR100417026B1 (enExample)
CN (4) CN1090676C (enExample)
AU (1) AU696358B2 (enExample)
CA (1) CA2153720A1 (enExample)
CZ (2) CZ293582B6 (enExample)
FI (1) FI953422L (enExample)
HU (2) HUT72922A (enExample)
IL (1) IL114582A0 (enExample)
MX (1) MX9503070A (enExample)
NO (1) NO952763L (enExample)
NZ (1) NZ272561A (enExample)
TW (1) TW459046B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904539D0 (sv) * 1999-12-10 1999-12-10 Alphahelix Ab Method and device for the handling of samples and reagents
FR2824334B1 (fr) * 2001-05-03 2003-10-10 Coletica Procede pour tester une substance eventuellement active dans le domaine de la lipolyse et son utilisation principalement cosmetique
AU2003288474A1 (en) * 2002-06-24 2004-03-19 Exiqon A/S Methods and systems for detection and isolation of a nucleotide sequence
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
CN101595228A (zh) 2005-07-21 2009-12-02 艾博特公司 包括sorf构建体的多基因表达和使用多蛋白、前体蛋白和蛋白酶解的方法
US20100035300A1 (en) * 2006-02-27 2010-02-11 Wang Andrew H-J Producing a Target Protein Using Intramolecular Cleavage by TEV Protease
US9206431B2 (en) * 2007-09-27 2015-12-08 Academia Sinica Kit for producing recombinant tag-cleavable fusion proteins via at least two different expression vectors allow protein production in two different species host cells
US8501449B2 (en) 2007-12-04 2013-08-06 Proteon Therapeutics, Inc. Recombinant elastase proteins and methods of manufacturing and use thereof
JP2013509188A (ja) * 2009-10-30 2013-03-14 アボット・ラボラトリーズ Ｓｏｒｆ構築物および複数の遺伝子発現

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3885431D1 (de) * 1987-12-23 1993-12-09 Boehringer Ingelheim Int Expression der viral kodierten Protease P2A des HRV2.
US5162601A (en) * 1989-11-22 1992-11-10 The Upjohn Company Plant potyvirus expression vector with a gene for protease
US6077694A (en) * 1990-09-21 2000-06-20 The United States Of America As Represented By The Department Of Health And Human Services Method for over-expression and rapid purification of biosynthetic proteins
RU2206611C2 (ru) * 1991-08-30 2003-06-20 Вертекс Фармасьютикалз Инкорпорейтед ФРАГМЕНТ ДНК, ПЛАЗМИДНЫЙ ВЕКТОР, СПОСОБ ПОЛУЧЕНИЯ ПОЛИПЕПТИДА И ПОЛИПЕПТИД, ОБЛАДАЮЩИЙ IL-1β ПРОТЕАЗНОЙ АКТИВНОСТЬЮ
AU1743795A (en) * 1994-02-03 1995-08-21 Scripps Research Institute, The A cassette to accumulate multiple proteins through synthesis of a self-processing polypeptide

Also Published As

Publication number Publication date
US5955072A (en) 1999-09-21
CN1126759A (zh) 1996-07-17
CZ180895A3 (en) 1996-02-14
AU2497095A (en) 1996-01-25
NZ272561A (en) 1997-03-24
FI953422A0 (fi) 1995-07-13
HU0202280D0 (enExample) 2002-09-28
NO952763L (no) 1996-01-15
HU9502114D0 (en) 1995-09-28
AU696358B2 (en) 1998-09-10
CN1385529A (zh) 2002-12-18
CA2153720A1 (en) 1996-01-14
CN1090676C (zh) 2002-09-11
CN1385532A (zh) 2002-12-18
CZ293582B6 (cs) 2004-06-16
NO952763D0 (no) 1995-07-12
TW459046B (en) 2001-10-11
EP1251176A3 (en) 2002-12-18
MX9503070A (es) 1997-01-31
KR100417026B1 (ko) 2004-05-17
US20030176688A1 (en) 2003-09-18
US6743611B2 (en) 2004-06-01
FI953422A7 (fi) 1996-01-14
FI953422L (fi) 1996-01-14
EP0700999A3 (en) 1997-04-16
US6307038B1 (en) 2001-10-23
EP1251176A2 (en) 2002-10-23
EP0700999A2 (en) 1996-03-13
CZ293745B6 (cs) 2004-07-14
CN1320689A (zh) 2001-11-07
IL114582A0 (en) 1995-11-27

Similar Documents

Publication Publication Date Title
CZ164994A3 (en) Human variant of kunitz-type protease inhibitor
IL94602A (en) Polypeptides and polypeptide equivalents
AU709054B2 (en) Compositions for the inhibition of TNF formation and uses thereof
JP2916228B2 (ja) 遺伝子操作した組み換えアプロチニン変異型、均質に処理されたアプロチニン変異型の微生物調製の方法およびその治療学的使用
US6307038B1 (en) Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
WO1994000555A2 (en) Compositions for the inhibition of protein hormone formation and uses thereof
CA2217450A1 (en) Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses
CN1798838A (zh) 一种蛋白酶的抑制剂蛋白及其用途
US5998378A (en) Compositions for the inhibition of TNF hormone formation and uses thereof
RU2143491C1 (ru) Полинуклеотидная последовательность (варианты), полипептид (варианты), слитый белок, фармацевтическая композиция, моноклональное антитело, штамм гибридных культивируемых клеток
WO1998020034A2 (en) Novel serine protease inhibitor nucleic acid molecules, proteins and uses thereof
US5459063A (en) Plasmodium falciparum ribonucleotide reductase DNA
NZ314127A (en) Coding sequence of the protease protein cyvv nia from clover yellow vein virus (potyvirus or plant rna virus) and uses thereof
HK1047601A (en) Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
HK1012024A (en) Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
US5843693A (en) Assay method for screening for inhibitors of proTNF conversion
US6586222B1 (en) Recombinant PR-3 and compositions thereof
AU687751C (en) Compositions for the inhibition of protein hormone formation and uses therof
JPH08131178A (ja) 還元能を有するタンパク質、及び該タンパク質をコードするｄｎａ
WO1994016062A1 (en) Complement regulatory proteins of herpesvirus saimiri
CN1495258A (zh) 金属蛋白酶-4的人组织抑制剂
JP2003033193A (ja) ヒトシスタチンｅ
CN1302875A (zh) 人夏科－莱登晶体5及其编码序列,以及制法和用途
CN1167502A (zh) 人dna连接酶iii
CN1268566A (zh) 一种新的人畸胎癌发生相关蛋白及其编码序列